Marios Politis
Marios Politis
Professor of Neurology @ University of Exeter
Verified email at - Homepage
Cited by
Cited by
Cognitive decline in Parkinson disease
D Aarsland, B Creese, M Politis, KR Chaudhuri, DH Ffytche, D Weintraub, ...
Nature Reviews Neurology 13 (4), 217-231, 2017
Parkinson's disease symptoms: the patient's perspective
M Politis, K Wu, S Molloy, P G. Bain, KR Chaudhuri, P Piccini
Movement Disorders 25 (11), 1646-1651, 2010
Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports
Z Kefalopoulou, M Politis, P Piccini, N Mencacci, K Bhatia, M Jahanshahi, ...
JAMA neurology 71 (1), 83-87, 2014
Serotonergic neurons mediate dyskinesia side effects in Parkinson’s patients with neural transplants
M Politis, K Wu, C Loane, NP Quinn, DJ Brooks, S Rehncrona, ...
Science translational medicine 2 (38), 38ra46-38ra46, 2010
The psychosis spectrum in Parkinson disease
DH Ffytche, B Creese, M Politis, KR Chaudhuri, D Weintraub, C Ballard, ...
Nature Reviews Neurology 13 (2), 81-95, 2017
Serotonin in Parkinson's disease
M Politis, F Niccolini
Behavioural brain research 277, 136-145, 2015
Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours
SS O’Sullivan, K Wu, M Politis, AD Lawrence, AH Evans, SK Bose, ...
Brain 134 (4), 969-978, 2011
Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment
A Chandra, G Dervenoulas, M Politis, ...
Journal of neurology 266, 1293-1302, 2019
Neuroimaging in Parkinson disease: from research setting to clinical practice
M Politis
Nature Reviews Neurology 10 (12), 708-722, 2014
Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study
M Politis, K Wu, C Loane, L Kiferle, S Molloy, DJ Brooks, P Piccini
Neurobiology of disease 40 (1), 216-221, 2010
Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients
M Politis, K Wu, C Loane, DJ Brooks, L Kiferle, FE Turkheimer, P Bain, ...
The Journal of clinical investigation 124 (3), 1340-1349, 2014
Buspirone: what is it all about?
C Loane, M Politis
Brain research 1461, 111-118, 2012
Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures
M Politis, K Wu, C Loane, FE Turkheimer, S Molloy, DJ Brooks, P Piccini
Neurology 75 (21), 1920-1927, 2010
Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study
M Politis, N Pavese, YF Tai, L Kiferle, SL Mason, DJ Brooks, SJ Tabrizi, ...
Human brain mapping 32 (2), 258-270, 2011
Imaging in Parkinson’s disease
G Pagano, F Niccolini, M Politis
Clinical Medicine 16 (4), 371-375, 2016
Advances in MRI methodology
T Yousaf, G Dervenoulas, M Politis
International review of neurobiology 141, 31-76, 2018
Clinical application of stem cell therapy in Parkinson's disease
M Politis, O Lindvall
BMC medicine 10, 1-7, 2012
Diabetes mellitus and Parkinson disease
G Pagano, S Polychronis, H Wilson, B Giordano, N Ferrara, F Niccolini, ...
Neurology 90 (19), e1654-e1662, 2018
Graft‐induced dyskinesias in Parkinson's disease: high striatal serotonin/dopamine transporter ratio
M Politis, WH Oertel, K Wu, NP Quinn, O Pogarell, DJ Brooks, A Bjorklund, ...
Movement Disorders 26 (11), 1997-2003, 2011
Hypothalamic involvement in Huntington's disease: an in vivo PET study
M Politis, N Pavese, YF Tai, SJ Tabrizi, RA Barker, P Piccini
Brain 131 (11), 2860-2869, 2008
The system can't perform the operation now. Try again later.
Articles 1–20